The company's innovative platform, "Deterministic Barcoding in Tissue for spatial-omics sequencing" (DBiT-seq), uses microfluidics and next-generation sequencing to create transformative multi-omic maps of proteomics, transcriptomics, and epigenomics in tissue at cellular resolution. This platform provides clinicians and researchers with unprecedented multi-omics tissue atlases, unlocking information about interactions between cells in localized neighborhoods. DBiT-seq is the first platform to offer spatial ATAC-seq and spatial CUT & Tag for mapping chromatin accessibility and histone modifications across the entire genome in tissue.